Literature DB >> 21602490

Human lung hydrolases delineate Mycobacterium tuberculosis-macrophage interactions and the capacity to control infection.

Jesús Arcos1, Smitha J Sasindran, Nagatoshi Fujiwara, Joanne Turner, Larry S Schlesinger, Jordi B Torrelles.   

Abstract

Pulmonary surfactant contains homeostatic and antimicrobial hydrolases. When Mycobacterium tuberculosis is initially deposited in the terminal bronchioles and alveoli, as well as following release from lysed macrophages, bacilli are in intimate contact with these lung surfactant hydrolases. We identified and measured several hydrolases in human alveolar lining fluid and lung tissue that, at their physiological concentrations, dramatically modified the M. tuberculosis cell envelope. Independent of their action time (15 min to 12 h), the effects of the hydrolases on the M. tuberculosis cell envelope resulted in a significant decrease (60-80%) in M. tuberculosis association with, and intracellular growth of the bacteria within, human macrophages. The cell envelope-modifying effects of the hydrolases also led to altered M. tuberculosis intracellular trafficking and induced a protective proinflammatory response to infection. These findings add a new concept to our understanding of M. tuberculosis-macrophage interactions (i.e., the impact of lung surfactant hydrolases on M. tuberculosis infection).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21602490      PMCID: PMC4201034          DOI: 10.4049/jimmunol.1100823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Allometric relationships of cell numbers and size in the mammalian lung.

Authors:  K C Stone; R R Mercer; P Gehr; B Stockstill; J D Crapo
Journal:  Am J Respir Cell Mol Biol       Date:  1992-02       Impact factor: 6.914

Review 2.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

3.  Alkaline phosphatase: a marker of alveolar type II cell differentiation.

Authors:  J D Edelson; J M Shannon; R J Mason
Journal:  Am Rev Respir Dis       Date:  1988-11

4.  Pulmonary lysozyme--a secretory protein of type II pneumocytes in the rat.

Authors:  G Singh; S L Katyal; W E Brown; D L Collins; R J Mason
Journal:  Am Rev Respir Dis       Date:  1988-11

5.  A specific acid alpha-glucosidase in lamellar bodies of the human lung.

Authors:  A C de Vries; A W Schram; J M Tager; J J Batenburg; L M van Golde
Journal:  Biochim Biophys Acta       Date:  1985-12-04

Review 6.  Synthesis of surfactant lipids in the adult lung.

Authors:  L M van Golde
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

Review 7.  Pulmonary surfactant.

Authors:  R J King
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-07

8.  Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains.

Authors:  D Chatterjee; K Lowell; B Rivoire; M R McNeil; P J Brennan
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

Review 9.  Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host.

Authors:  Jordi B Torrelles; Larry S Schlesinger
Journal:  Tuberculosis (Edinb)       Date:  2010-03-03       Impact factor: 3.131

10.  Immunocytochemical localization of lysozyme and surfactant protein A in rat type II cells and extracellular surfactant forms.

Authors:  E M Haller; S A Shelley; M R Montgomery; J U Balis
Journal:  J Histochem Cytochem       Date:  1992-10       Impact factor: 2.479

View more
  34 in total

Review 1.  Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Authors:  Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  Vaccine       Date:  2015-08-28       Impact factor: 3.641

Review 2.  Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us.

Authors:  Tracy L Keiser; Georgiana E Purdy
Journal:  Microbiol Spectr       Date:  2017-06

Review 3.  Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis.

Authors:  Anca Dorhoi; Stefan H E Kaufmann
Journal:  Semin Immunopathol       Date:  2015-10-05       Impact factor: 9.623

4.  Lung Mucosa Lining Fluid Modification of Mycobacterium tuberculosis to Reprogram Human Neutrophil Killing Mechanisms.

Authors:  Jesús Arcos; Lauren E Diangelo; Julia M Scordo; Smitha J Sasindran; Juan I Moliva; Joanne Turner; Jordi B Torrelles
Journal:  J Infect Dis       Date:  2015-03-06       Impact factor: 5.226

Review 5.  Tuberculosis in the elderly: Why inflammation matters.

Authors:  Tucker J Piergallini; Joanne Turner
Journal:  Exp Gerontol       Date:  2017-12-26       Impact factor: 4.032

Review 6.  Integrating Lung Physiology, Immunology, and Tuberculosis.

Authors:  Jordi B Torrelles; Larry S Schlesinger
Journal:  Trends Microbiol       Date:  2017-03-30       Impact factor: 17.079

Review 7.  Macrophage immunoregulatory pathways in tuberculosis.

Authors:  Murugesan V S Rajaram; Bin Ni; Claire E Dodd; Larry S Schlesinger
Journal:  Semin Immunol       Date:  2014-10-30       Impact factor: 11.130

8.  Molecular composition of the alveolar lining fluid in the aging lung.

Authors:  Juan I Moliva; Murugesan V S Rajaram; Sabeen Sidiki; Smitha J Sasindran; Evelyn Guirado; Xueliang Jeff Pan; Shu-Hua Wang; Patrick Ross; William P Lafuse; Larry S Schlesinger; Joanne Turner; Jordi B Torrelles
Journal:  Age (Dordr)       Date:  2014-03-03

Review 9.  Alveolar Epithelial Cells in Mycobacterium tuberculosis Infection: Active Players or Innocent Bystanders?

Authors:  Julia M Scordo; Daren L Knoell; Jordi B Torrelles
Journal:  J Innate Immun       Date:  2015-09-18       Impact factor: 7.349

Review 10.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.